Delivery Method: subcutaneous or intravenous injection
fluoroestradiol F 18
Delivery Method: injection
for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B-cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia
